retatrutide safe safety profile clinical trials The FDA has issued warning letters to multiple companies marketing compounded Retatrutide After Bariatric Surgery: Is

GLP-1 & GIP Therapy Why Nuviva

CrossRef Significance of FXR agonists in MASLD treatment: a deep dive into lipid alteration by analytical techniques Pirangi Srikanth, Khaja Moinuddin Shaik, Vijay Patibandla, Deepak Kumar, Sukhendu Nandi Exploration of Endocrine and Metabolic Diseases .2025;[Epub] CrossRef Editorial: Chrononutrition and MASLDIts About Time (Restricted Feeding)

You lost the weight now what

Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis

Data from clinical studies In an observational study involving 20 diabetic subjects receiving background metformin therapy, exenatide treatment over 16 weeks resulted in improved flow-mediated vasodilation of the brachial artery following 5 min of forearm ischemia, as assessed by ultrasound echocardiography, compared to patients treated with glimepiride [85]

Eli Lilly and Company Redefining metabolic healthcare through its leadership in diabetes and obesity treatments